|
End-of-day quote
NSE India S.E.
20/11/2026
|
5-day change | 1st Jan Change | ||
| 1,480.20 INR | +0.13% |
|
+1.80% | +24.76% |
| 11-05 | Global Health Passes the Health Check But Challenges Remain | |
| 11-04 | Global Health Limited, Q2 2027 Earnings Call, Nov 04, 2026 |
| Market Cap | 398B 4.3B 3.91B 3.61B 3.28B 6.16B 6.47B 43.9B 17.45B 217B 16.13B 15.79B 682B | P/E 2027 * |
52.2x | P/E 2028 * | 42.7x |
|---|---|---|---|---|---|
| Enterprise Value | 393B 4.24B 3.86B 3.56B 3.24B 6.07B 6.38B 43.31B 17.22B 214B 15.91B 15.58B 673B | EV / Sales 2027 * |
7.08x | EV / Sales 2028 * | 6.2x |
| Free-Float |
33.6% | Yield 2027 * |
0.04% | Yield 2028 * | 0.06% |
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| MEDANTA | End-of-day quote | |
| MEDANTA | Delayed |
Last Transcript: Global Health Limited
| 1 day | +0.13% | ||
| 1 week | +1.80% | ||
| Current month | +16.52% | ||
| 1 month | +19.55% | ||
| 3 months | +5.11% | ||
| 6 months | +19.36% | ||
| Current year | +24.76% |
| 1 week | 1,424 | 1,509.3 | |
| 1 month | 1,165 | 1,509.3 | |
| Current year | 956 | 1,544 | |
| 1 year | 956 | 1,544 | |
| 3 years | 888.95 | 1,544 | |
| 5 years | 390.55 | 1,544 | |
| 10 years | 390.55 | 1,544 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 15/09/2017 | |
| Director of Finance/CFO | 29 | 08/02/2024 | |
Rajiv Sikka
CTO | Chief Tech/Sci/R&D Officer | - | 06/11/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 80 | 07/02/2014 | |
Sunil Sachdeva
BRD | Director/Board Member | 61 | 13/08/2004 |
| Director/Board Member | 72 | 06/10/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.13% | +1.80% | +22.02% | +65.04% | 4.3B | ||
| +1.00% | -9.52% | +6.31% | +18.43% | 103B | ||
| +3.31% | -4.70% | -0.15% | +91.45% | 99.34B | ||
| -5.70% | -14.32% | +21.21% | +399.00% | 39.62B | ||
| -0.73% | -0.48% | +14.07% | +94.82% | 31.77B | ||
| -0.47% | -0.90% | +40.41% | +73.91% | 29.81B | ||
| -0.31% | -0.51% | +37.67% | +91.53% | 28.42B | ||
| -0.15% | -7.99% | +40.98% | +305.22% | 20.95B | ||
| -0.62% | -2.67% | -15.69% | -20.65% | 19.39B | ||
| 0.00% | -0.38% | -2.83% | +32.77% | 16.97B | ||
| Average | -0.35% | -3.76% | +16.40% | +115.15% | 39B | |
| Weighted average by Cap. | +0.37% | -5.76% | +12.19% | +105.19% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 55.43B 599M 545M 502M 457M 857M 901M 6.11B 2.43B 30.27B 2.25B 2.2B 95.01B | 63.34B 684M 623M 574M 522M 980M 1.03B 6.99B 2.78B 34.6B 2.57B 2.51B 109B |
| Net income | 7.63B 82.4M 75.05M 69.15M 62.9M 118M 124M 842M 335M 4.17B 309M 303M 13.08B | 9.35B 101M 92.01M 84.78M 77.12M 145M 152M 1.03B 410M 5.11B 379M 371M 16.03B |
| Net Debt | -5.31B -57.3M -52.19M -48.09M -43.74M -82.06M -86.24M -585M -233M -2.9B -215M -210M -9.09B | -5.35B -57.74M -52.59M -48.46M -44.08M -82.7M -86.91M -590M -234M -2.92B -217M -212M -9.17B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/11/26 | ₹1,480.20 | +0.13% | 265,365 |
| 19/11/26 | ₹1,478.30 | +2.90% | 282,387 |
| 18/11/26 | ₹1,436.60 | -0.53% | 127,395 |
| 17/11/26 | ₹1,444.20 | +0.74% | 200,782 |
| 16/11/26 | ₹1,433.60 | -1.40% | 134,996 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- MEDANTA Stock
Select your edition
All financial news and data tailored to specific country editions

















